Get the NVAX Research Report and
Also Receive Our Top Trades for 2017!

Novavax, Inc.

On May 11, 2017, Novavax, Inc., announced that Dr. James F. Cummings has been promoted to Vice President, Clinical Development and Translational Medicine. Dr. Cummings joined Novavax as Senior Director of Clinical Development in September 2015, with a specific focus on advancing Novavax’ programs within emerging infectious disease. Previously, Dr. Cummings served as the Director for Global Emerging Infections Surveillance and Response System (GEIS) at the Armed Forces Health Surveillance Branch … (See Research Report)
Download Research Report
on NVAX Now